Top Stories

Attracting & Hiring the “1%er” by Creating a Brand (Part 2)

By Joseph Mullings     Landing the 1%ers is becoming more challenging. Cross-over markets where the top performers like software developers, engineers, UI/UX rock stars, for the most part, can seamlessly go from consumer electronics, to med-tech, to social media to bio-tech to space-tech markets. [...]

Attracting & Hiring the “1%er” by Creating a Brand (Part 1)

By Joseph Mullings     I do quite a bit of consulting for companies who are constantly challenged with attracting best in class talent. The conversation invariably revolves around “How can I compete with the Apple’s, Tesla’s, Google’s or GE’s of the world?” I instantly [...]

Careers: Are You Signed Up For the Right Race?

By Joseph Mullings     So you need to know what kind of daily race you have signed up for.  For the most part, a career runs a similar race every day. Company culture, rate of work, expectations and sacrifice are all part of the [...]

International News

Cardiac Dimensions® Initiates European Commercialization of CARILLON® Mitral Contour System®

Commercial Rollout includes PRIME Study, Collecting Data on up to 300 European Patients KIRKLAND, Wash., Sept. 28, 2012 — /PRNewswire/ --Cardiac Dimensions®,Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its [...]

$265 million for Israeli-founded medical device company

An admirable exit for the Israeli-founded medical device company, Rhythmia Medical, as it gets picked up by Boston Scientific – a worldwide developer, manufacturer and marketer of medical devices- for $265 million. The agreement (signed today) calls for an upfront payment of $90 million payable [...]

Implant scandal sparks revamp of EU medical device rules

*Rules to tighten product approvals, safety checks * Changes follow French breast implant safety scandal * Plans must be approved by EU governments, lawmakers BRUSSELS, Sept 26 (Reuters) - The European Union has proposed tougher rules on assessing the safety and monitoring the use of [...]

European regulators approve Surefire Infusion System for chemo – and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately. "Surefire Medical developed this ground-breaking technology to provide interventional [...]